These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 20179214)

  • 1. Accurate outcome prediction in neuroblastoma across independent data sets using a multigene signature.
    De Preter K; Vermeulen J; Brors B; Delattre O; Eggert A; Fischer M; Janoueix-Lerosey I; Lavarino C; Maris JM; Mora J; Nakagawara A; Oberthuer A; Ohira M; Schleiermacher G; Schramm A; Schulte JH; Wang Q; Westermann F; Speleman F; Vandesompele J
    Clin Cancer Res; 2010 Mar; 16(5):1532-41. PubMed ID: 20179214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification.
    Oberthuer A; Berthold F; Warnat P; Hero B; Kahlert Y; Spitz R; Ernestus K; König R; Haas S; Eils R; Schwab M; Brors B; Westermann F; Fischer M
    J Clin Oncol; 2006 Nov; 24(31):5070-8. PubMed ID: 17075126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of gene expression-based classification for neuroblastoma.
    Oberthuer A; Hero B; Berthold F; Juraeva D; Faldum A; Kahlert Y; Asgharzadeh S; Seeger R; Scaruffi P; Tonini GP; Janoueix-Lerosey I; Delattre O; Schleiermacher G; Vandesompele J; Vermeulen J; Speleman F; Noguera R; Piqueras M; Bénard J; Valent A; Avigad S; Yaniv I; Weber A; Christiansen H; Grundy RG; Schardt K; Schwab M; Eils R; Warnat P; Kaderali L; Simon T; Decarolis B; Theissen J; Westermann F; Brors B; Fischer M
    J Clin Oncol; 2010 Jul; 28(21):3506-15. PubMed ID: 20567016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression signatures predict outcome in non-muscle-invasive bladder carcinoma: a multicenter validation study.
    Dyrskjøt L; Zieger K; Real FX; Malats N; Carrato A; Hurst C; Kotwal S; Knowles M; Malmström PU; de la Torre M; Wester K; Allory Y; Vordos D; Caillault A; Radvanyi F; Hein AM; Jensen JL; Jensen KM; Marcussen N; Orntoft TF
    Clin Cancer Res; 2007 Jun; 13(12):3545-51. PubMed ID: 17575217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of neuronal genes defines subtypes of disseminated neuroblastoma with favorable and unfavorable outcome.
    Fischer M; Oberthuer A; Brors B; Kahlert Y; Skowron M; Voth H; Warnat P; Ernestus K; Hero B; Berthold F
    Clin Cancer Res; 2006 Sep; 12(17):5118-28. PubMed ID: 16951229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reanalysis of neuroblastoma expression profiling data using improved methodology and extended follow-up increases validity of outcome prediction.
    Schramm A; Mierswa I; Kaderali L; Morik K; Eggert A; Schulte JH
    Cancer Lett; 2009 Sep; 282(1):55-62. PubMed ID: 19349112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixture classification model based on clinical markers for breast cancer prognosis.
    Zeng T; Liu J
    Artif Intell Med; 2010; 48(2-3):129-37. PubMed ID: 20005686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-study analysis of gene expression data for intermediate neuroblastoma identifies two biological subtypes.
    Warnat P; Oberthuer A; Fischer M; Westermann F; Eils R; Brors B
    BMC Cancer; 2007 May; 7():89. PubMed ID: 17531100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis of gene expression profiles related to relapse-free survival in 1,079 breast cancer patients.
    Györffy B; Schäfer R
    Breast Cancer Res Treat; 2009 Dec; 118(3):433-41. PubMed ID: 19052860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translating expression profiling into a clinically feasible test to predict neuroblastoma outcome.
    Schramm A; Vandesompele J; Schulte JH; Dreesmann S; Kaderali L; Brors B; Eils R; Speleman F; Eggert A
    Clin Cancer Res; 2007 Mar; 13(5):1459-65. PubMed ID: 17332289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression-based recurrence prediction of hepatitis B virus-related human hepatocellular carcinoma.
    Woo HG; Park ES; Cheon JH; Kim JH; Lee JS; Park BJ; Kim W; Park SC; Chung YJ; Kim BG; Yoon JH; Lee HS; Kim CY; Yi NJ; Suh KS; Lee KU; Chu IS; Roskams T; Thorgeirsson SS; Kim YJ
    Clin Cancer Res; 2008 Apr; 14(7):2056-64. PubMed ID: 18381945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of 70-gene prognosis signature in node-negative breast cancer.
    Bueno-de-Mesquita JM; Linn SC; Keijzer R; Wesseling J; Nuyten DS; van Krimpen C; Meijers C; de Graaf PW; Bos MM; Hart AA; Rutgers EJ; Peterse JL; Halfwerk H; de Groot R; Pronk A; Floore AN; Glas AM; Van't Veer LJ; van de Vijver MJ
    Breast Cancer Res Treat; 2009 Oct; 117(3):483-95. PubMed ID: 18819002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges in projecting clustering results across gene expression-profiling datasets.
    Lusa L; McShane LM; Reid JF; De Cecco L; Ambrogi F; Biganzoli E; Gariboldi M; Pierotti MA
    J Natl Cancer Inst; 2007 Nov; 99(22):1715-23. PubMed ID: 18000217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression signature predicts recurrence in lung adenocarcinoma.
    Larsen JE; Pavey SJ; Passmore LH; Bowman RV; Hayward NK; Fong KM
    Clin Cancer Res; 2007 May; 13(10):2946-54. PubMed ID: 17504995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple gene expression classifiers from different array platforms predict poor prognosis of colorectal cancer.
    Lin YH; Friederichs J; Black MA; Mages J; Rosenberg R; Guilford PJ; Phillips V; Thompson-Fawcett M; Kasabov N; Toro T; Merrie AE; van Rij A; Yoon HS; McCall JL; Siewert JR; Holzmann B; Reeve AE
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):498-507. PubMed ID: 17255271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of recurrence-free survival in postoperative non-small cell lung cancer patients by using an integrated model of clinical information and gene expression.
    Lee ES; Son DS; Kim SH; Lee J; Jo J; Han J; Kim H; Lee HJ; Choi HY; Jung Y; Park M; Lim YS; Kim K; Shim Y; Kim BC; Lee K; Huh N; Ko C; Park K; Lee JW; Choi YS; Kim J
    Clin Cancer Res; 2008 Nov; 14(22):7397-404. PubMed ID: 19010856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constructing molecular classifiers for the accurate prognosis of lung adenocarcinoma.
    Guo L; Ma Y; Ward R; Castranova V; Shi X; Qian Y
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3344-54. PubMed ID: 16740756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classification of neuroblastoma patients by published gene-expression markers reveals a low sensitivity for unfavorable courses of MYCN non-amplified disease.
    Oberthuer A; Warnat P; Kahlert Y; Westermann F; Spitz R; Brors B; Hero B; Eils R; Schwab M; Berthold F; Fischer M
    Cancer Lett; 2007 Jun; 250(2):250-67. PubMed ID: 17126996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling in uveal melanoma: two regions on 3p related to prognosis.
    van Gils W; Lodder EM; Mensink HW; Kiliç E; Naus NC; Brüggenwirth HT; van Ijcken W; Paridaens D; Luyten GP; de Klein A
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4254-62. PubMed ID: 18552379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting the site of origin of tumors by a gene expression signature derived from normal tissues.
    Staub E; Buhr HJ; Gröne J
    Oncogene; 2010 Aug; 29(31):4485-92. PubMed ID: 20514016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.